Phase II Open Label Trial to Determine Safety & Efficacy of Tisagenlecleucel in Pediatric Non-Hodgkin Lymphoma Patients
Clinical trial NCT03610724 · COMPLETED
Trial details
- NCT number
- NCT03610724
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-15
- Primary completion
- 2021-07-27
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.